Chemical Formula: C20H31NO3

Chemical Formula C20H31NO3

Found 15 metabolite its formula value is C20H31NO3

Carbetapentane

2-[2-(diethylamino)Ethoxy]ethyl 1-phenylcyclopentane-1-carboxylic acid

C20H31NO3 (333.2304)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membran σ1, respectively. Pentoxyverine is a muscarinic antagonist. Pentoxyverine is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].

   

Ethyl 2-[2-(diethylamino)ethoxy]-1-phenylcyclopentane-1-carboxylate

Ethyl 2-[2-(diethylamino)ethoxy]-1-phenylcyclopentane-1-carboxylic acid

C20H31NO3 (333.2304)


   

Stearidonoyl glycine

2-(6Z,9Z,12Z,15Z)-octadeca-tetraenamidoacetic acid

C20H31NO3 (333.2304)


   
   

Pentoxyverine

carbetapentane

C20H31NO3 (333.2304)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents Pentoxyverine (Carbetapentane) is an orally active sigma-1 receptor agonist, with Kis of 41 nM, 894 nM and 75 nM for σ1, σ2 and guinea-pig brain membran σ1, respectively. Pentoxyverine is a muscarinic antagonist. Pentoxyverine is a potent antitussive, anticonvulsant, and spasmolytic agent. Pentoxyverine can be used for inhibiting bronchial interceptor, weakening of cough reflex, bronchial smooth muscle relaxation and reduction of airway resistance[1][2][3][4].

   

carbetapentane

carbetapentane

C20H31NO3 (333.2304)


   

NA-Gly 18:4(6Z,9Z,12Z,15Z)

NA-Gly 18:4(6Z,9Z,12Z,15Z)

C20H31NO3 (333.2304)


   
   
   

(5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

(5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

C20H31NO3 (333.2304)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1r,2r)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1r,2r)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

(1e,5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

(1e,5r,10s)-3,17,17-trimethyl-7-methylidene-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-1,14-diene-5,14,16-triol

C20H31NO3 (333.2304)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1s,2s)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-[(1s,2s)-2-methylcyclopropyl]trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)


   

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

(2z,6z,8z,12e)-n-(1,3-dihydroxypropan-2-yl)-13-(2-methylcyclopropyl)trideca-2,6,8,12-tetraenimidic acid

C20H31NO3 (333.2304)